Lisanti Capital Growth LLC Has $561,000 Stake in Astera Labs, Inc. $ALAB

Lisanti Capital Growth LLC cut its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 88.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,865 shares of the company’s stock after selling 21,315 shares during the period. Lisanti Capital Growth LLC’s holdings in Astera Labs were worth $561,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Astera Labs by 21.6% in the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after buying an additional 2,624 shares in the last quarter. Maryland State Retirement & Pension System increased its position in shares of Astera Labs by 37.7% during the 2nd quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock worth $629,000 after purchasing an additional 1,906 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Astera Labs by 94.6% during the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock valued at $9,908,000 after purchasing an additional 53,276 shares during the last quarter. Vanguard Personalized Indexing Management LLC grew its stake in Astera Labs by 142.4% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 11,366 shares of the company’s stock worth $1,028,000 after buying an additional 6,677 shares during the last quarter. Finally, Realta Investment Advisors acquired a new stake in shares of Astera Labs during the second quarter worth approximately $214,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Down 6.1%

Shares of Astera Labs stock opened at $150.62 on Friday. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The business has a fifty day simple moving average of $163.98 and a 200 day simple moving average of $171.15. The stock has a market cap of $25.44 billion, a PE ratio of 135.69, a price-to-earnings-growth ratio of 2.19 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. During the same period last year, the company posted $0.23 EPS. Astera Labs’s revenue for the quarter was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several research analyst reports. Bank of America assumed coverage on Astera Labs in a research report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price objective for the company. Raymond James Financial assumed coverage on shares of Astera Labs in a report on Friday, November 21st. They set a “hold” rating on the stock. Wall Street Zen downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. TD Cowen reissued a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. Finally, Morgan Stanley restated an “overweight” rating and issued a $210.00 price objective on shares of Astera Labs in a research report on Wednesday, December 3rd. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and an average price target of $190.63.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 90,459 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief operating officer owned 1,599,750 shares in the company, valued at approximately $231,467,827.50. The trade was a 5.35% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, General Counsel Philip Mazzara sold 4,620 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $668,467.80. Following the transaction, the general counsel directly owned 147,040 shares of the company’s stock, valued at $21,275,217.60. This represents a 3.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 576,936 shares of company stock worth $87,409,540 in the last 90 days. Company insiders own 12.50% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.